Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Change in Account Payables (2022 - 2025)

Taysha Gene Therapies (TSHA) has disclosed Change in Account Payables for 4 consecutive years, with -$2.1 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 41.36% to -$2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$153000.0 through Dec 2025, up 94.76% year-over-year, with the annual reading at -$153000.0 for FY2025, 94.76% up from the prior year.
  • Change in Account Payables hit -$2.1 million in Q4 2025 for Taysha Gene Therapies, down from -$1.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.0 million in Q1 2024 to a low of -$9.4 million in Q3 2022.
  • Historically, Change in Account Payables has averaged -$823250.0 across 4 years, with a median of -$1.4 million in 2023.
  • Biggest YoY gain for Change in Account Payables was 1008.64% in 2024; the steepest drop was 191.55% in 2024.
  • Year by year, Change in Account Payables stood at -$4.6 million in 2022, then surged by 73.19% to -$1.2 million in 2023, then decreased by 22.28% to -$1.5 million in 2024, then crashed by 41.36% to -$2.1 million in 2025.
  • Business Quant data shows Change in Account Payables for TSHA at -$2.1 million in Q4 2025, -$1.9 million in Q3 2025, and $3.0 million in Q2 2025.